Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses

Cellular Microbiology

Volumn 15, Issue 4, 2013, Pages 660-674

  Afonso Barroso, António ^a   Clark, Simon O ^b   Williams, Ann ^b   Rosa, Gustavo T ^a   Nóbrega, Cláudia ^c   Silva Gomes, Sandro ^a   Vale Costa, Sílvia ^a   Ummels, Roy ^d   Stoker, Neil ^e   Movahedzadeh, Farahnaz ^e,f   van der Ley, Peter ^g   Sloots, Arjen ^g   Cot, Marlène ^h,i   Appelmelk, Ben J ^d   Puzo, Germain ^h,i   Nigou, Jérôme ^h,i   Geurtsen, Jeroen ^d   Appelberg, Rui ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF MINHO   (Portugal)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ROYAL VETERINARY COLLEGE   (United Kingdom)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^h INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

ⁱ UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOARABINOMANNAN; MANNOSE; LIPOPOLYSACCHARIDE; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CELL DIVISION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE MODEL; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION; MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REDUNDANCY ANALYSIS; UPREGULATION; ANIMAL; CHEMISTRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; GUINEA PIG; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG TUBERCULOSIS; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOLOGY;

ANIMALIA; CAVIA; CORYNEBACTERINEAE; MUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; LIPOPOLYSACCHARIDES; MACROPHAGES; MANNOSE; MICE; MICROBIAL VIABILITY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, PULMONARY; VIRULENCE FACTORS;

EID: 84874977321     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12065     Document Type: Article

References (51)

1. Adams, L.B., Fukutomi, Y., and Krahenbuhl, J.L. (1993) Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun 61: 4173-4181.
2. Appelmelk, B.J., Verwey-van Vught, A.M., Maaskant, J.J., Schouten, W.F., Thijs, L.G., and Maclaren, D.M. (1986) Use of mucin and hemoglobin in experimental murine gram-negative bacteremia enhances the immunoprotective action of antibodies reactive with the lipopolysaccharide core region. Antonie Van Leeuwenhoek 52: 537-542.
3. Appelmelk, B.J., den Dunnen, J., Driessen, N.N., Ummels, R., Pak, M., Nigou, J., etal. (2008) The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol 10: 930-944.
4. Bradbury, M.G., and Moreno, C. (1993) Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages. Clin Exp Immunol 94: 57-63.
5. Briken, V., Porcelli, S.A., Besra, G.S., and Kremer, L. (2004) Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Mol Microbiol 53: 391-403.
6. Chambers, M.A., Williams, A., Gavier-Widen, D., Whelan, A., Hall, G., Marsh, P.D., etal. (2000) Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M.bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Infect Immun 68: 7094-7099.
7. Chan, J., Fan, X., Hunter, S.W., Brennan, P.J., and Bloom, B.R. (1991) Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 59: 1755-1761.
8. Chatterjee, D., and Khoo, K.H. (1998) Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8: 113-120.
9. Chatterjee, D., Roberts, A.D., Lowell, K., Brennan, P.J., and Orme, I.M. (1992) Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun 60: 1249-1253.
10. Clark, S.O., Hall, Y., Kelly, D.L., Hatch, G.J., and Williams, A. (2011) Survival of Mycobacterium tuberculosis during experimental aerosolization and implications for aerosol challenge models. J Appl Microbiol 111: 350-359.
11. Colditz, G.A., Brewer, T.F., Berkey, C.S., Wilson, M.E., Burdick, E., Fineberg, H.V., and Mosteller, F. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702.
12. Dinadayala, P., Kaur, D., Berg, S., Amin, A.G., Vissa, V.D., Chatterjee, D., etal. (2006) Genetic basis for the synthesis of the immunomodulatory mannose caps of lipoarabinomannan in Mycobacterium tuberculosis. J Biol Chem 281: 20027-20035.
13. Driessen, N.N., Ummels, R., Maaskant, J.J., Gurcha, S.S., Besra, G.S., Ainge, G.D., etal. (2009) Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. Infect Immun 77: 4538-4547.
14. Festjens, N., Bogaert, P., Batni, A., Houthuys, E., Plets, E., Vanderschaeghe, D., etal. (2011) Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M.tuberculosis. EMBO Mol Med 3: 222-234.
15. Fratti, R.A., Chua, J., Vergne, I., and Deretic, V. (2003) Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci USA 100: 5437-5442.
16. Geijtenbeek, T.B., Van Vliet, S.J., Koppel, E.A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C.M., Appelmelk, B., and Van Kooyk, Y. (2003) Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197: 7-17.
17. Geurtsen, J., Chedammi, S., Mesters, J., Cot, M., Driessen, N.N., Sambou, T., etal. (2009) Identification of mycobacterial alpha-glucan as a novel ligand for DC-SIGN: involvement of mycobacterial capsular polysaccharides in host immune modulation. J Immunol 183: 5221-5231.
18. Gheorghiu, M., Mouton, D., Lecoeur, H., Lagranderie, M., Mevel, J.C., and Biozzi, G. (1985) Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria. Clin Exp Immunol 59: 177-184.
19. Gilleron, M., Quesniaux, V.F., and Puzo, G. (2003) Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 278: 29880-29889.
20. Gilleron, M., Jackson, M., Nigou, J., and Puzo, G. (2008) Structure, biosynthesis, and activities of the phosphatidyl-myo-inositol based lipoglycans. In The Mycobacterial Cell Envelope. Daffé, M., and Reyrat, J.-M. (eds). Washington, DC: ASM Press, pp. 75-105.
21. Guerardel, Y., Maes, E., Elass, E., Leroy, Y., Timmerman, P., Besra, G.S., etal. (2002) Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with alpha 1, 3-mannopyranose side chains. J Biol Chem 277: 30635-30648.
22. Hartings, J.M., and Roy, C.J. (2004) The automated bioaerosol exposure system: preclinical platform development and a respiratory dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49: 39-55.
23. Kang, P.B., Azad, A.K., Torrelles, J.B., Kaufman, T.M., Beharka, A., Tibesar, E., etal. (2005) The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 202: 987-999.
24. Khoo, K.H., Dell, A., Morris, H.R., Brennan, P.J., and Chatterjee, D. (1995) Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J Biol Chem 270: 12380-12389.
25. Knutson, K.L., Hmama, Z., Herrera-Velit, P., Rochford, R., and Reiner, N.E. (1998) Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes. J Biol Chem 273: 645-652.
26. Lever, M.S., Williams, A., and Bennett, A.M. (2000) Survival of mycobacterial species in aerosols generated from artificial saliva. Lett Appl Microbiol 31: 238-241.
27. Maeda, N., Nigou, J., Herrmann, J.L., Jackson, M., Amara, A., Lagrange, P.H., etal. (2003) The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 278: 5513-5516.
28. Mishra, A.K., Driessen, N.N., Appelmelk, B.J., and Besra, G.S. (2011) Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev 35: 1126-1157.
29. Murray, P.J. (1999) Defining the requirements for immunological control of mycobacterial infections. Trends Microbiol 7: 366-372.
30. Nigou, J., Vercellone, A., and Puzo, G. (2000) New structural insights into the molecular deciphering of mycobacterial lipoglycan binding to C-type lectins: lipoarabinomannan glycoform characterization and quantification by capillary electrophoresis at the subnanomole level. J Mol Biol 299: 1353-1362.
31. Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., and Puzo, G. (2001) Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol 166: 7477-7485.
32. Nigou, J., Gilleron, M., Rojas, M., Garcia, L.F., Thurnher, M., and Puzo, G. (2002) Mycobacterial lipoarabinomannans: modulators of the dendritic cell function and the apoptotic response. Microbes Infect 4: 945-953.
33. Nigou, J., Gilleron, M., and Puzo, G. (2003) Lipoarabinomannans: from structure to biosynthesis. Biochimie 85: 153-166.
34. Pais, T.F., Cunha, J.F., and Appelberg, R. (2000) Antigen specificity of T-cell response to Mycobacterium avium infection in mice. Infect Immun 68: 4805-4810.
35. Parish, T., and Stoker, N.G. (2000) Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146: 1969-1975.
36. Park, C.G., Takahara, K., Umemoto, E., Yashima, Y., Matsubara, K., Matsuda, Y., etal. (2001) Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int Immunol 13: 1283-1290.
37. Pathak, S.K., Basu, S., Bhattacharyya, A., Pathak, S., Kundu, M., and Basu, J. (2005) Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J Biol Chem 280: 42794-42800.
38. Pitarque, S., Herrmann, J.L., Duteyrat, J.L., Jackson, M., Stewart, G.R., Lecointe, F., etal. (2005) Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem J 392: 615-624.
39. Prigozy, T.I., Sieling, P.A., Clemens, D., Stewart, P.L., Behar, S.M., Porcelli, S.A., etal. (1997) The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6: 187-197.
40. Reiling, N., Ehlers, S., and Holscher, C. (2008) MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Immunol Lett 116: 15-23.
41. Roach, T.I.A., Barton, C.H., Chatterjee, D., and Blackwell, J.M. (1993) Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-α. J Immunol 150: 1886-1896.
42. Schlesinger, L. (1993) Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 150: 2920-2930.
43. Schlesinger, L.S., Hull, S.R., and Kaufman, T.M. (1994) Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 152: 4070-4079.
44. Sibley, L.D., Hunter, S.W., Brennan, P.J., and Krahenbuhl, J.L. (1988) Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun 56: 1232-1236.
45. Sieling, P.A., Chatterjee, D., Porcelli, S.A., Prigozy, T.I., Mazzaccaro, R.J., Soriano, T., etal. (1995) CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269: 227-230.
46. Tailleux, L., Schwartz, O., Herrmann, J.L., Pivert, E., Jackson, M., Amara, A., etal. (2003) DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197: 121-127.
47. Torrelles, J.B., Azad, A.K., and Schlesinger, L.S. (2006) Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol 177: 1805-1816.
48. Vergne, I., Chua, J., and Deretic, V. (2003) Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade. J Exp Med 198: 653-659.
49. Welin, A., Winberg, M.E., Abdalla, H., Sarndahl, E., Rasmusson, B., Stendahl, O., and Lerm, M. (2008) Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect Immun 76: 2882-2887.
50. Williams, A., Davies, A., Marsh, P.D., Chambers, M.A., and Hewinson, R.G. (2000) Comparison of the protective efficacy of bacille Calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. Clin Infect Dis 30: 299-301.
51. Yoshida, A., and Koide, Y. (1997) Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect Immun 65: 1953-1955.